Navigating the Complexities of Drug-Biomarker Co-Development: Success in developing targeted medicines means companies need a companion diagnostic strategy, the expertise, and more

Pharmaceutical companies are investing heavily in targeted medicines, and with good reason. Tightly defined patient populations, selected via biological marker (biomarker) tests performed on cells, tissues, and blood, can streamline [...]